I'm LongbridgeAI, I can summarize articles.IBM (IBM) rose 3.58% this week to close at $243.29, versus $234.89 at the end of the prior week. The S&P 500 fell 0.8% over the same stretch, leaving IBM about 4.38 percentage points ahead of the benchmark. Daily moves were choppy before the late push higher: Tuesday’s session opened at $232.95 and closed at $232.09, Wednesday jumped to $239.94, Thursday slipped back to $234.02, and Friday climbed to $243.29, finishing near the week’s high.
The Week
IBM (IBM) rose 3.58% this week to close at $243.29, versus $234.89 at the end of the prior week. The S&P 500 fell 0.8% over the same stretch, leaving IBM about 4.38 percentage points ahead of the benchmark. Daily moves were choppy before the late push higher: Tuesday’s session opened at $232.95 and closed at $232.09, Wednesday jumped to $239.94, Thursday slipped back to $234.02, and Friday climbed to $243.29, finishing near the week’s high.
Key Events
The week’s news flow centred on quantum computing and AI. In quantum, IBM and Lockheed Martin announced a Swiss Quantum Innovation Hub at ETH Zurich anchored by Switzerland’s first IBM quantum computer, while a Cleveland Clinic, RIKEN and IBM team advanced to the finals for the 2026 ACM Gordon Bell Prize. Separately, Japan’s NEC halted its quantum computer project after decades of research, drawing attention to IBM’s continuing quantum investments. On the AI side, IBM collaborated with LTM and Red Hat on Lightwell, an AI-driven open-source vulnerability remediation tool, and with NASA on an AI model to help map ice and craters on the Moon. Several institutions also disclosed new or increased IBM positions during the week, including Legal & General Group acquiring 6,666,667 shares and CIBC World Market buying 371,017 shares.
Analyst Ratings
IBM is covered by 26 institutions, with 10 buy ratings, 3 overweight, 10 hold, 1 underweight, 1 sell, and 1 no opinion. That makes 13 buy or overweight and 2 underweight or sell. The consensus rating is buy, with a consensus target price of $245.35, roughly 0.85% above the latest close. The target range is wide—from $174.00 to $350.00—signalling meaningful dispersion across analysts. IBM ranks 3rd by rating within the IT consulting industry, which has 35 covered names.
The Week Ahead
The macro calendar picks up next week. Watch the New York Fed manufacturing index on 15 September, then on 16 September the retail sales releases, retail sales ex-autos, import price index and NAHB housing market index. IBM’s next earnings release is scheduled for 21 October after market close, with estimates at $2.489 EPS and $16.8 billion in revenue. There is no IBM earnings next week, but retail and manufacturing data will provide incremental reads on end demand and enterprise IT spending.
In Short
IBM closed near the top of its weekly range and outperformed the S&P 500 by 4.38 percentage points. The consensus rating remains buy and the consensus target sits above spot, though the wide target range points to disagreement about the long-term story. On valuation, the stock trades at roughly 21.4x P/E and 6.7x P/B. The latest session’s money flow shows mid-size and small-lot flows skewed to inflows, but that snapshot is not enough to establish a weekly trend. Going forward, the question is whether the quantum and AI collaborations translate into sustained revenue contribution, and how macro data shapes risk appetite for tech names.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.